Compounded tirzepatide and the Ivím weight loss program

A weekly GLP-1 injection to lose weight, curb hunger, and regulate blood sugar.*

Starting at $199/mo

FDA notice on Zepbound™/Mounjaro® shortage: On December 19, 2024, the U.S. Food and Drug Administration determined that the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, had ended. (Read more)

At Ivím, we are deeply committed to supporting our patients and empowering our providers to prioritize your health and wellness. We strive to help you discover the best available therapies and personalize them to align with your individual goals.

As part of your Ivím membership, we are working diligently to ensure access to safe and effective therapies that support your overall metabolic health. This includes facilitating insurance access to trusted name-brand treatments, providing exclusive Ivím discounts on name-brand medications, and offering customized compounded solutions tailored to your needs.

^*While federal law allows the prescription of compounded drugs, they are not FDA-approved and do not undergo safety, effectiveness, or manufacturing review. For additional safety information, please see our Safety Page.

Tirzepatide is presently only available as prescription brand name products, Mounjaro® and Zepbound™ *. Compounded tirzepatide belongs to the same class of drugs known as GLP-1 receptor agonists. Individuals may be prescribed compounded tirzepatide for various reasons, such as requiring a unique formulation, facing insurance denial for brand name coverage, seeking cost savings, or experiencing a local drug shortage.

Drug compounding is legal and a well-accepted practice in the United States. It is the process of combining, mixing, or changing ingredients to create a medication specific to the needs of an individual patient. Ivím only selects FDA-inspected, state-regulated compounding pharmacies that meet regulatory board standards for quality and safety to fulfill our compounded tirzepatide prescriptions for our patients.

Your Ivím medical provider will evaluate your eligibility based on your medical questionnaire and discuss your compounded GLP-1 medication options. Compounded tirzepatide may be prescribed based on your personal weight loss needs. Individuals may be prescribed compounded tirzepatide for various reasons, such as requiring a unique formulation, facing insurance denial for brand name coverage, seeking cost savings, or experiencing a local drug shortage.

Compounded tirzepatide medication is not covered by insurance, but Ivím provides affordable pricing options to ensure your weight loss goals stay within reach. Often, compounded tirzepatide medication will be substantially less than the retail price of the name brand FDA-approved brand name drugs Mounjaro® and Zepbound™ *.

Yes! Compounded tirzepatide medication can be paid for with your HSA or FSA card.

*Disclaimer: Mounjaro® and Zepbound™ are both registered trademarks of Eli Lilly. Ivím is not affiliated with Eli Lilly.